US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 3.1200
- +0.1900+6.48%
Close Jan 3 16:00 ET
- 3.1000
- -0.0200-0.64%
Post 20:01 ET
3.95MMarket Cap-0.21P/E (TTM)
3.2100High2.8100Low62.46KVolume2.9200Open2.9300Pre Close187.74KTurnover6.87%Turnover RatioLossP/E (Static)1.27MShares9.250052wk High0.22P/B2.84MFloat Cap2.370052wk Low--Dividend TTM908.92KShs Float170.0000Historical High--Div YieldTTM13.65%Amplitude2.3700Historical Low3.0050Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Pasithea Therapeutics Stock Forum
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
54 seconds ago, 4:02 AM PST
Via GlobeNewswire
-- SRC recommended that the trial escalate to the next dose level of 15mg capsule --
-- No dose-limiting toxicities (DLTs) observed to date --
-- No rash observed to date --
📊⚡️📊
Pasithea Therapeutics Announces $5 Million Private Placement Priced at-the-Market Under Nasdaq Rules
No comment yet